Clinical Trial

Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic

Study acronym: RC
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated March 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-01; most recent amendment 2024-09-11.
Status change: Not Yet Recruiting → Recruiting 2024-07-29
Trial Details
NCT Number NCT06345716
Lead Sponsor University of Monastir
Conditions Renal Colic
Enrollment 1,500 participants
Start Date 2024-04-10
Primary Completion 2025-03-15 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-19